bert van der reijden

Associate professor Molecular Hematology

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Bert van der Reijden is an Associate Professor in Molecular Hematology at Radboud UMC, Netherlands. His research focuses on acute myeloid leukemia, chronic myeloid leukemia, and clonal hematopoiesis, as evidenced by his recent publications on the genetic underpinnings and clinical outcomes associated with these conditions. He is actively involved in investigating novel therapeutic approaches and the implementation of digital care platforms for hematological patients.

Articles (11)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Erik van den Akker

Delft University of Technology

NETHERLANDS

View details

Marieke Griffioen

Associate Professor

Leiden University Medical Center

NETHERLANDS

View details

Charlotte Bekker

Radboud University Medical Center

NETHERLANDS

View details

Rosella Hermens

Radboud University Medical Center

NETHERLANDS

View details

Priscilla Kamphuis

University Medical Center Groningen

NETHERLANDS

View details

Nicole M.A. Blijlevens

Radboud University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

bert van der reijden

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Acute myeloid leukemia associated RUNX1 variants induce aberrant expression of transcription factor TCF4

Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses

Improvement, Implementation, and Evaluation of the CMyLife Digital Care Platform: Participatory Action Research Approach

Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial

BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population

Clonal Hematopoiesis Defined by Somatic Mutations Infrequently Co-occurs With Mosaic Loss of the Y Chromosome in a Population-based Cohort

High expression of an intragenic long noncoding RNA misinterpreted as high FTO oncogene expression in NPM1 mutant acute myeloid leukemia

Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years

A collapse for venous thromboembolism

Collaborators (6)

Erik van den Akker

Marieke Griffioen

Charlotte Bekker

Rosella Hermens

Priscilla Kamphuis

Nicole M.A. Blijlevens

Make your next move.